• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于超高效液相色谱-高分辨质谱的血清非靶向脂质组学用于发现结直肠高级别腺瘤的潜在生物标志物

Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.

作者信息

Zhu Yifan, Wang Lisheng, Nong Yanying, Liang Yunxiao, Huang Zongsheng, Zhu Pingchuan, Zhang Qisong

机构信息

Medical College of Guangxi University, Guangxi University, Nanning, Guangxi, 530004, People's Republic of China.

Department of Gastroenterology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, 530011, People's Republic of China.

出版信息

Cancer Manag Res. 2021 Nov 26;13:8865-8878. doi: 10.2147/CMAR.S336322. eCollection 2021.

DOI:10.2147/CMAR.S336322
PMID:34858060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8632617/
Abstract

BACKGROUND

As a key precancerous lesion, colorectal advanced adenoma (CAA) is closely related to the occurrence and development of colorectal cancer (CRC). Effective identification of CAA-related biomarkers can prevent CRC morbidity and mortality. Lipids, as an important endogenous substance, have been proved to be involved in the occurrence and development of CRC. Lipidomics is an advanced technique that studies lipid metabolism and biomarkers of diseases. However, there are no lipidomics studies based on large serum samples to explore diagnostic biomarkers for CAA.

METHODS

An integrated serum lipid profile from 50 normal (NR) and 46 CAA subjects was performed using ultra-high performance liquid chromatography tandem high-resolution mass spectrometry (UHPLC-HRMS). Lipidomic data were acquired for negative and positive ionization modes, respectively. Differential lipids were selected by univariate and multivariate statistics analyses. A receiver operator characteristic curve (ROC) analysis was conducted to evaluate the diagnostic performance of differential lipids.

RESULTS

A total of 53 differential lipids were obtained by combining univariate and multivariate statistical analyses ( < 0.05 and VIP > 1). In addition, 12 differential lipids showed good diagnostic performance (AUC > 0.90) for the discrimination of NR and CAA by receiver operating characteristic curve (ROC) analysis. Of them, the performance of PC 44:5 and PC 35:6e presented the outstanding performance (AUC = 1.00, (95% CI, 1.00-1.00)). Moreover, triglyceride (TAG) had the highest proportion (37.74%) as the major dysregulated lipids in the CAA.

CONCLUSION

This is the first study that profiled serum lipidomics and explored lipid biomarkers with good diagnostic ability of CAA to contribute to the early prevention of CRC. Twelve differential lipids that effectively discriminate between NR and CAA serve as the potential diagnostic markers of CAA. An obvious perturbation of TAG metabolism could be involved in the CAA formation.

摘要

背景

作为一种关键的癌前病变,结直肠高级别腺瘤(CAA)与结直肠癌(CRC)的发生发展密切相关。有效识别与CAA相关的生物标志物可预防CRC的发病和死亡。脂质作为一种重要的内源性物质,已被证明参与CRC的发生发展。脂质组学是一项研究脂质代谢和疾病生物标志物的先进技术。然而,尚无基于大样本血清的脂质组学研究来探索CAA的诊断生物标志物。

方法

使用超高效液相色谱串联高分辨率质谱(UHPLC-HRMS)对50名正常(NR)受试者和46名CAA受试者的血清脂质谱进行综合分析。分别在负离子和正离子模式下获取脂质组学数据。通过单变量和多变量统计分析选择差异脂质。进行受试者工作特征曲线(ROC)分析以评估差异脂质的诊断性能。

结果

通过单变量和多变量统计分析相结合,共获得53种差异脂质(<0.05且VIP>1)。此外,通过受试者工作特征曲线(ROC)分析,12种差异脂质对NR和CAA的鉴别显示出良好的诊断性能(AUC>0.90)。其中,PC 44:5和PC 35:6e的性能表现突出(AUC = 1.00,(95%CI,1.00 - 1.00))。此外,甘油三酯(TAG)作为CAA中主要失调的脂质,所占比例最高(37.74%)。

结论

这是第一项对血清脂质组进行分析并探索具有良好CAA诊断能力的脂质生物标志物以促进CRC早期预防的研究。有效区分NR和CAA的12种差异脂质可作为CAA的潜在诊断标志物。TAG代谢的明显紊乱可能参与了CAA的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/bba202fd9ff4/CMAR-13-8865-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/c8edd7113c87/CMAR-13-8865-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/5f050058ee9e/CMAR-13-8865-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/210853381cf5/CMAR-13-8865-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/7b534a7576d7/CMAR-13-8865-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/3e76574f48e6/CMAR-13-8865-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/caf02f31d4fc/CMAR-13-8865-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/25cdbab35782/CMAR-13-8865-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/bba202fd9ff4/CMAR-13-8865-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/c8edd7113c87/CMAR-13-8865-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/5f050058ee9e/CMAR-13-8865-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/210853381cf5/CMAR-13-8865-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/7b534a7576d7/CMAR-13-8865-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/3e76574f48e6/CMAR-13-8865-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/caf02f31d4fc/CMAR-13-8865-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/25cdbab35782/CMAR-13-8865-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefc/8632617/bba202fd9ff4/CMAR-13-8865-g0008.jpg

相似文献

1
Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.基于超高效液相色谱-高分辨质谱的血清非靶向脂质组学用于发现结直肠高级别腺瘤的潜在生物标志物
Cancer Manag Res. 2021 Nov 26;13:8865-8878. doi: 10.2147/CMAR.S336322. eCollection 2021.
2
UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.基于 UHPLC-HRMS 的血清非靶向脂质组学:磷脂酰胆碱和神经鞘磷脂是区分结直肠高级腺瘤与癌症的主要失调脂质标志物。
J Pharm Biomed Anal. 2023 Sep 20;234:115582. doi: 10.1016/j.jpba.2023.115582. Epub 2023 Jul 16.
3
Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.UHPLC-ESI-HRMS 进行非靶向脂质组学分析有助于结直肠腺瘤的生物标志物发现。
BMC Cancer. 2022 Mar 24;22(1):314. doi: 10.1186/s12885-022-09427-1.
4
UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.基于 UHPLC-HRMS 的多组学研究探索结直肠癌的潜在机制和生物标志物。
BMC Cancer. 2024 May 27;24(1):644. doi: 10.1186/s12885-024-12321-7.
5
UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer.基于超高效液相色谱-高分辨质谱的血清脂质组学揭示了有助于鉴别结直肠癌和腺瘤的新型生物标志物。
Front Oncol. 2022 Jul 28;12:934145. doi: 10.3389/fonc.2022.934145. eCollection 2022.
6
[Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].[血清非靶向代谢组学与靶向胆汁酸代谢组学的综合分析用于鉴定结直肠癌诊断生物标志物]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Mar 20;43(3):443-453. doi: 10.12122/j.issn.1673-4254.2023.03.15.
7
A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.血清脂质组学策略揭示了早期宫颈癌的潜在脂质生物标志物。
Life Sci. 2020 Nov 1;260:118489. doi: 10.1016/j.lfs.2020.118489. Epub 2020 Sep 23.
8
Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.采用超高效液相色谱-串联质谱技术鉴定活动性肺结核的潜在脂质生物标志物。
Exp Biol Med (Maywood). 2021 Feb;246(4):387-399. doi: 10.1177/1535370220968058. Epub 2020 Nov 11.
9
HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease.基于高分辨质谱的非靶向脂质组学揭示威尔逊病的特征性脂质图谱。
Front Pharmacol. 2021 Nov 22;12:754185. doi: 10.3389/fphar.2021.754185. eCollection 2021.
10
Comprehensive serum lipidomic analyses reveal potential biomarkers for malignant breast cancer: A case-control study.综合血清脂质组学分析揭示恶性乳腺癌的潜在生物标志物:病例对照研究。
Cancer Biomark. 2023;37(4):289-297. doi: 10.3233/CBM-220462.

引用本文的文献

1
The Utility of Lipidomic Analysis in Colorectal Cancer Diagnosis and Prognosis-A Systematic Review of Recent Literature.脂质组学分析在结直肠癌诊断和预后中的应用——近期文献的系统评价。
Int J Mol Sci. 2024 Jul 14;25(14):7722. doi: 10.3390/ijms25147722.
2
[Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].[血清非靶向代谢组学与靶向胆汁酸代谢组学的综合分析用于鉴定结直肠癌诊断生物标志物]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Mar 20;43(3):443-453. doi: 10.12122/j.issn.1673-4254.2023.03.15.
3
Lipid Biomarkers in Liquid Biopsies: Novel Opportunities for Cancer Diagnosis.

本文引用的文献

1
Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies.结直肠癌中的微卫星不稳定性:致癌作用、新抗原、免疫抗性及新兴疗法
Cancers (Basel). 2021 Jun 19;13(12):3063. doi: 10.3390/cancers13123063.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma.
液体活检中的脂质生物标志物:癌症诊断的新机遇
Pharmaceutics. 2023 Jan 28;15(2):437. doi: 10.3390/pharmaceutics15020437.
4
UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer.基于超高效液相色谱-高分辨质谱的血清脂质组学揭示了有助于鉴别结直肠癌和腺瘤的新型生物标志物。
Front Oncol. 2022 Jul 28;12:934145. doi: 10.3389/fonc.2022.934145. eCollection 2022.
5
Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.UHPLC-ESI-HRMS 进行非靶向脂质组学分析有助于结直肠腺瘤的生物标志物发现。
BMC Cancer. 2022 Mar 24;22(1):314. doi: 10.1186/s12885-022-09427-1.
用于早期检测结直肠癌和进展性腺瘤的新型血清自身抗体生物标志物的鉴定与验证
Front Oncol. 2020 Jul 22;10:1081. doi: 10.3389/fonc.2020.01081. eCollection 2020.
4
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer.血清微小RNA-592可作为结直肠癌早期诊断的一种新型潜在生物标志物。
Oncol Lett. 2020 Aug;20(2):1119-1126. doi: 10.3892/ol.2020.11682. Epub 2020 May 28.
5
Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge.通过液体活检检测结直肠癌和进展期腺瘤(Decalib研究):数字滴度PCR的挑战
Cancers (Basel). 2020 Jun 6;12(6):1482. doi: 10.3390/cancers12061482.
6
A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.联合脂质组学方法揭示了血浆乙醇胺磷脂酰基醇和脂肪酸作为结直肠癌患者的早期诊断生物标志物。
Expert Rev Proteomics. 2020 Mar;17(3):233-242. doi: 10.1080/14789450.2020.1757443. Epub 2020 May 4.
7
The Metabolic Changes of Artesunate and Ursolic Acid on Syrian Golden Hamsters Fed with the High-Fat Diet.高脂饮食对金黄地鼠体内青蒿琥酯和熊果酸代谢的影响。
Molecules. 2020 Mar 18;25(6):1392. doi: 10.3390/molecules25061392.
8
LC-HRMS based approach to identify novel sphingolipid biomarkers in breast cancer patients.基于 LC-HRMS 的方法鉴定乳腺癌患者新型神经酰胺生物标志物。
Sci Rep. 2020 Mar 13;10(1):4668. doi: 10.1038/s41598-020-61283-w.
9
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.结直肠腺瘤患者粪便代谢组学特征与肠道微生物群及结直肠癌发病早期事件相关。
mBio. 2020 Feb 18;11(1):e03186-19. doi: 10.1128/mBio.03186-19.
10
Endoscopic diagnosis and treatment planning for colorectal polyps using a deep-learning model.使用深度学习模型进行结直肠息肉的内镜诊断和治疗计划。
Sci Rep. 2020 Jan 8;10(1):30. doi: 10.1038/s41598-019-56697-0.